Currently, TTF-1 expression is standard for NSCLC subtype differentiation and NGS for genetic background, but this is not sufficient for pulmonary metastases (especially thyroid and colorectal carcinomas, which are sometimes positive for TTF-1 and BRAF mutation). This evidence concerns the gene BRAF and non-small cell lung carcinoma.